Lung cancer from suspicion to treatment: An indicator of healthcare access in Turkey
Deniz Kızılırmak,Zeynep Yılmaz Kaya,Gizem Gökçimen,Yavuz Havlucu,Beyhan Cengiz Özyurt,Baran Gündoğuş,Dorina Esendağlı,Bilkay Serez Kaya,İlker Yılmam,Yusuf Aydemir,Mücahit Çolak,Emine Afşin,Nazlı Çetin,Aytekin İdikut,Ceren Değirmenci,Özge Oral Tapan,Canan Gündüz Gürkan,Celalettin İbrahim Kocatürk,Gökçen Ömeroğlu Şimşek,Cem Emrah Kalafat,Elif Yelda Özgün Niksarlıoğlu,Merdiye Ergün Serdaroğlu,Oğuz Karcıoğlu,Songül Özyurt,Elvin Karahacıoğlu Madran,Büşra Yaprak Bayrak,Zenfira Alasgarova,Oya Baydar Toprak,Elif Yılmazel Uçar,Burcu Nur Topal,Serap Argun Barış,Elif Guliyev,Efraim Güzel,Salih Küçük,Birsen Ocaklı,Burcu Baran Ketencioğlu,Nursel Türkoğlu Selçuk,Merve Sarı Akyüz,Eylem Sercan Özgür,Nur Aleyna Yetkin,Pelin Duru Çetinkaya,Pelin Pınar Deniz,Siahmet Atlı,Hatice Çetindoğan,Fatma Gülsüm Karakaş,Emine Serap Yılmaz,Dilek Ergün,Recai Ergün,Cumhur Murat Tulay,Meftun Ünsal,İlker Demirkaya,Feride Marım,İlknur Kaya,Ezgi Demirdöğen,Aslı Görek Dilektaşlı,Ahmet Ursavaş,Pınar Çelik
DOI: https://doi.org/10.1016/j.canep.2023.102480
Abstract:Background: Lung cancer is the leading cause of cancer-related deaths worldwide. Before beginning lung cancer treatment, it is necessary to complete procedures such as suspecting lung cancer, obtaining a pathologic diagnosis, and staging. This study aimed to investigate the processes from suspicion of lung cancer to diagnosis, staging, and treatment initiation. Methods: The study was designed as a multicenter and cross-sectional study. Patients with lung cancer from various health institutions located in all geographic regions of Turkey were included in the study. The sociodemographic and clinical characteristics of the patients, the characteristics of the health institutions and geographic regions, and other variables of the lung cancer process were recorded. The time from suspicion of lung cancer to pathologic diagnosis, radiologic staging, and treatment initiation, as well as influencing factors, were investigated. Results: The study included 1410 patients from 29 different medical centers. The mean time from the initial suspicion of lung cancer to the pathologic diagnosis was 48.0 ± 52.6 days, 39.0 ± 52.7 days for radiologic staging, and 74.9 ± 65.5 days for treatment initiation. The residential areas with the most suspected lung cancer cases were highly developed socioeconomic zones. Primary healthcare services accounted for only 0.4% of patients with suspected lung cancer. The time to pathologic diagnosis was longer in the Marmara region, and the wait time for staging and treatment initiation was longer in Eastern and Southeastern Anatolia. Patients who presented to chest disease referral hospitals with peripheral lesions, those with early-stage disease, and those who were diagnosed surgically had significantly longer wait times. Conclusion: The time between pathologic diagnosis, staging, and treatment initiation in lung cancer was longer than expected. Increasing the role of primary healthcare services and distributing socioeconomic resources more equally will contribute to shortening the time to diagnosis and improve treatment processes for lung cancer.